NHS England, Biogen reach deal on pricey drug for deadly disorder


NHS England, Biogen reach deal on pricey drug for deadly disorderNHS England said it reached a "managed access agreement" with Biogen under which it will fund treatment for a limited time and collect data on the drug's effectiveness. NHS England did not disclose the price it will pay for the drug. The rejection came despite a lower British price tag of 450,000 pounds ($573,000) for the first year and Biogen offering an undisclosed discount to the National Health Service.



Tags: England, Science, NHS, NHS england, Biogen, NHS England Biogen

Source:  https://news.yahoo.com/nhs-england-biogen-reach-deal-pricey-drug-deadly-230522262--finance.html